|
|
|
|
Questioning The Credibility Of Some Published Clinical Trials
Randomised Controlled Trials (RCTs) are considered the 'gold standard' research method for assessing new medical treatments.But research published in BioMed Central's open access journal Trials shows that the design of a...
|
|
|
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
SAN DIEGO, June 30 /PRNewswire/ -- Accumetrics, Inc.announces that it has reached the halfway mark (1,600 patients) in the enrollment of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow(R) Assay Impact...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Vancouver, BC--(Marketwire) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being...
|
|
|
India needs to allow phase I trials of new drugs developed abroad: Dr Nadig
Indian regulatory authorities should allow to conduct phase 1 study for compounds developed abroad if its expertise and skill to invent new drugs is to be recognized internationally according to Dr Ramanand Nadig, president and deputy dean...
|
|
|
Medical News: Saint Barnabas Medical Center Is Only Hospital In New Jersey To Offer Clinical Trial For The Tre
Barnabas Medical Center Is Only Hospal In New Jersey To Offer Clinical Trial For The Treatment Of Recurrent Chest Wall News Arce [] Web Wikipedia Medical Dictionary [] News Saint Barnabas Medical Center Is Only Hospal In New...
|
|
|
Medical News: Sucampo Reports Top-Line Results Of Phase 2 Clinical Trial Of Cobiprostone For Prevention Of NSA
GastroIntestinal / Gastroenterology News Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials email to a friend printer friendly view / write opinions rate article Current...
|
|
|
XenoPort Reports Positive Results From A Phase 2 Trial Of Arbaclofen Placarbil In Spinal Cord Injury Patients
Also Included In: Clinical Trials / Drug Trials email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: XenoPort, Inc....
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
-(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER, BRITISH COLUMBIA, Jul 02 (MARKET WIRE) -- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/02/09 -- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
(Marketwire via COMTEX) -- TKMRF | Quote | Chart | News | PowerRating -- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
VANCOUVER (Marketwire) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX:TKM - News) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for...
|
|
|
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
Mark J.Murray, Tekmira's President and CEO, said 'We are very excited to initiate the ApoB SNALP Phase 1 clinical trial representing our first RNAi therapeutic clinical trial and an important milestone for Tekmira. Our...
|
|
|
Pfizer Discontinues Phase 3 Trial Of Sutent(R) In Metastatic Colorectal Cancer
Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment...
|
|
|
Choosing a Clinical Trial Disclosure System
Best Practices and Technology Help Ensure Compliance and Minimize Disruption Satish Tadikonda New and evolving laws, mandates, and guidance from regulatory bodies and international health organizations necessitate that all companies...
|
|
|
Pfizer Discontinues Phase 3 Trial of Sutent in Metastatic Colorectal Cancer
Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment...
|
|
|
Medical News: Sepracor Provides Update On Clinical Trials For SEP-225289 And LUNESTA(R) Pediatrics
Main Category: Depression Also Included In: Clinical Trials / Drug Trials; Pediatrics / Children's Health email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public:...
|
